Nadav Kidron
2015
In 2015, Nadav Kidron earned a total compensation of $765.2K as President and CEO and director at Oramed Pharmaceuticals, a 5% decrease compared to previous year.
Compensation breakdown
| Bonus | $63,045 |
|---|---|
| Salary | $254,318 |
| Stock Awards | $431,645 |
| Other | $16,217 |
| Total | $765,225 |
Kidron received $431.6K in stock awards, accounting for 56% of the total pay in 2015.
Kidron also received $63K in bonus, $254.3K in salary and $16.2K in other compensation.
Rankings
In 2015, Nadav Kidron's compensation ranked 9,165th out of 13,638 executives tracked by ExecPay. In other words, Kidron earned more than 32.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,165 out of 13,638 | 33rd |
Division Manufacturing | 3,487 out of 5,187 | 33rd |
Major group Chemicals And Allied Products | 1,278 out of 1,857 | 31st |
Industry group Drugs | 1,041 out of 1,531 | 32nd |
Industry Pharmaceutical Preparations | 807 out of 1,179 | 32nd |
Source: SEC filing on July 31, 2017.
Kidron's colleagues
We found three more compensation records of executives who worked with Nadav Kidron at Oramed Pharmaceuticals in 2015.